Abaxys Therapeutics

Abaxys Therapeutics is a biopharmaceutical company aiming to accelerate the development of highly innovative programs with strong therapeutic potential. Our Vision & Mission: Abaxys Therapeutics aims to become a key player and first-choice partner in the area of human CNS diseases contributing to the development of highly innovative therapeutic solutions for neurological and neurodegenerative diseases, including neuro-orphan diseases. We aim for a significant reduction of time-to-clinics of preclinical programs and contribute to develop efficaeous disease modifying therapies for brain neurodegenerative diseases Our strategy is based on a business model which uses the local and European top R&D ecosystem to deliver disruptive preclinical packages contributing to high value pharma therapeutic programs. Our team has a long experience in pharmaceutical research in neurosciences and company creation in the area of Biotechnology. We have a strong commitment to capitalize the value of our team and our partners for delivering successful medicines for patients.